512 related articles for article (PubMed ID: 26502220)
1. Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.
Sussman JB; Kerr EA; Saini SD; Holleman RG; Klamerus ML; Min LC; Vijan S; Hofer TP
JAMA Intern Med; 2015 Dec; 175(12):1942-9. PubMed ID: 26502220
[TBL] [Abstract][Full Text] [Related]
2. Control of glycemia and blood pressure in British adults with diabetes mellitus and subsequent therapy choices: a comparison across health states.
McAlister FA; Lethebe BC; Lambe C; Williamson T; Lowerison M
Cardiovasc Diabetol; 2018 Feb; 17(1):27. PubMed ID: 29433515
[TBL] [Abstract][Full Text] [Related]
3. Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes.
Niznik JD; Hunnicutt JN; Zhao X; Mor MK; Sileanu F; Aspinall SL; Springer SP; Ersek MJ; Gellad WF; Schleiden LJ; Hanlon JT; Thorpe JM; Thorpe CT
J Am Geriatr Soc; 2020 Apr; 68(4):736-745. PubMed ID: 32065387
[TBL] [Abstract][Full Text] [Related]
4. Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes.
Lederle LI; Steinman MA; Jing B; Nguyen B; Lee SJ
J Am Geriatr Soc; 2022 Jul; 70(7):2019-2028. PubMed ID: 35318647
[TBL] [Abstract][Full Text] [Related]
5. Treatment Deintensification Is Uncommon in Adults With Type 2 Diabetes Mellitus: A Retrospective Cohort Study.
McAlister FA; Youngson E; Eurich DT
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28416531
[TBL] [Abstract][Full Text] [Related]
6. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
Sonmez A; Tasci I; Demirci I; Haymana C; Barcin C; Aydin H; Cetinkalp S; Ozturk FY; Gul K; Sabuncu T; Satman I; Bayram F;
Diabetes Ther; 2020 May; 11(5):1045-1059. PubMed ID: 32088879
[TBL] [Abstract][Full Text] [Related]
7. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.
Rehman H; Akeroyd JM; Ramsey D; Ahmed ST; Merchant AT; Navaneethan SD; Petersen LA; Virani SS
Clin Cardiol; 2017 Nov; 40(11):1055-1060. PubMed ID: 28841246
[TBL] [Abstract][Full Text] [Related]
8. Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries.
Maciejewski ML; Mi X; Sussman J; Greiner M; Curtis LH; Ng J; Haffer SC; Kerr EA
J Gen Intern Med; 2018 Jan; 33(1):34-41. PubMed ID: 28905179
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Diabetes Medication Intensifications in Older Adults Discharged From US Veterans Health Administration Hospitals.
Anderson TS; Lee S; Jing B; Fung K; Ngo S; Silvestrini M; Steinman MA
JAMA Netw Open; 2020 Mar; 3(3):e201511. PubMed ID: 32207832
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes.
Weinstock RS; Trief PM; Burke BK; Wen H; Liu X; Kalichman S; Anderson BJ; Bulger JD
JAMA Netw Open; 2023 Oct; 6(10):e2336964. PubMed ID: 37792373
[TBL] [Abstract][Full Text] [Related]
11. Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer.
Sun L; Parikh RB; Hubbard RA; Cashy J; Takvorian SU; Vaughn DJ; Robinson KW; Narayan V; Ky B
JAMA Netw Open; 2021 Feb; 4(2):e210070. PubMed ID: 33625512
[TBL] [Abstract][Full Text] [Related]
12. Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes.
Alexopoulos AS; Kahkoska AR; Pate V; Bradley MC; Niznik J; Thorpe C; Stürmer T; Buse J
JAMA Netw Open; 2021 Nov; 4(11):e2132215. PubMed ID: 34726745
[TBL] [Abstract][Full Text] [Related]
13. A Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications.
Pilla SJ; Meza KA; Schoenborn NL; Boyd CM; Maruthur NM; Chander G
J Gen Intern Med; 2023 Mar; 38(4):1008-1015. PubMed ID: 36175758
[TBL] [Abstract][Full Text] [Related]
14. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD011798. PubMed ID: 30246878
[TBL] [Abstract][Full Text] [Related]
15. Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
Tseng CL; Soroka O; Maney M; Aron DC; Pogach LM
JAMA Intern Med; 2014 Feb; 174(2):259-68. PubMed ID: 24322626
[TBL] [Abstract][Full Text] [Related]
16. Mortality associated with less intense risk-factor control among adults with diabetes in the United States.
Saydah SH; Gregg EW; Kahn HS; Ali MK
Prim Care Diabetes; 2018 Feb; 12(1):3-12. PubMed ID: 28797537
[TBL] [Abstract][Full Text] [Related]
17. What matters in ADVANCE and ADVANCE-ON.
Hamet P
Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():20-9. PubMed ID: 22118707
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
[TBL] [Abstract][Full Text] [Related]
19. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
Safai N; Carstensen B; Vestergaard H; Ridderstråle M
BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
[TBL] [Abstract][Full Text] [Related]
20. Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication.
Mancia G; Cannon CP; Tikkanen I; Zeller C; Ley L; Woerle HJ; Broedl UC; Johansen OE
Hypertension; 2016 Dec; 68(6):1355-1364. PubMed ID: 27977392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
